Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

F-Star Therapeutics Inc (NQ: FSTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about F-Star Therapeutics Inc

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
From invoX Pharma
Via Business Wire
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender Offer 
From F-star Therapeutics, Inc.
Via GlobeNewswire
invoX Pharma and F-star Therapeutics issue Joint Statement
From F-star Therapeutics, Inc.
Via GlobeNewswire
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
FS222 demonstrated early antitumor activity with one complete response and six disease stabilizations in patients with advanced solid tumors 
From F-star Therapeutics, Inc.
Via GlobeNewswire
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
From F-star Therapeutics, Inc.
Via GlobeNewswire
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX
From Kahn Swick & Foti, LLC
Via Business Wire
FSTX STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX
From Kahn Swick & Foti, LLC
Via Business Wire
FSTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.